Unlike CAR-T cells, T cell receptor (TCR)-T cells target solid tumors primarily by recognizing intracellular tumor antigens presented by major histocompatibility complex (MHC) and engaging in CD3 signaling mechanisms (13). The gene discussed is HLA-C; the disease is neoplasm.